Dn B Asset Management As Aerie Pharmaceuticals Inc Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 06, 2021
SELL
$15.16 - $18.97 $214,195 - $268,027
-14,129 Closed
0 $0
Q1 2021

Apr 15, 2021
SELL
$13.12 - $20.9 $1.18 Million - $1.88 Million
-90,073 Reduced 86.44%
14,129 $252,000
Q4 2020

Jan 19, 2021
BUY
$9.12 - $14.49 $950,322 - $1.51 Million
104,202 New
104,202 $1.41 Million

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email